person · Reporting owner
Rosebrough Walter M Jr
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | Director | September 11, 2026 | September 15, 2026 |
| STERIS plcSTE · Entity 3228 | Director · President & CEO | November 09, 2020 | November 10, 2020 |
| Varex Imaging CorpVREX · Entity 5135 | Director | February 12, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date September 11, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectsee footnote | 20,000 |
Last balance in matching sequence
After 2026-09-14 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2026-09-11 · Purchase · Acquired 7,000 · Balance 17,000 F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $53.15 to $54.50. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee. Row 3 · 2026-09-14 · Purchase · Acquired 3,000 · Balance 20,000 F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.00 to $54.44. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F2: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee. |
| Common StockSEC Table I · non-derivative | Direct | 832 |
Reported balance
Holding disclosure · report date 2026-09-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 832 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $53.15 to $54.50. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2: Shares held by the Walter M Rosebrough, Jr Revocable Trust, of which the Reporting Person is sole trustee.
F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.00 to $54.44. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
STERIS plc
Report date November 09, 2020 · Filed November 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 58,391 |
Reported balance
After 2020-11-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-09 · Sale · Disposed 3,014 · Balance 58,391 F1: Price reflects a weighted average sale price for multiple transactions ranging from $192.66 to $193.64 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 51,605 |
Reported balance
After 2020-11-09 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-11-09 · Sale · Disposed 6,786 · Balance 51,605 F2: Price reflects a weighted average sale price for multiple transactions ranging from $193.83 to $194.71 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 51,405 |
Reported balance
After 2020-11-09 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2020-11-09 · Sale · Disposed 200 · Balance 51,405 F3: These 51,405 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F4: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Price reflects a weighted average sale price for multiple transactions ranging from $192.66 to $193.64 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: Price reflects a weighted average sale price for multiple transactions ranging from $193.83 to $194.71 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: These 51,405 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit.
F4: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024.
Varex Imaging Corp
Report date February 12, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,947 |
Reported balance
After 2026-02-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-12 · Grant · Acquired 14,947 · Balance 14,947 F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.
F2: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 48,895 · Balance 0 F1: These 48,895 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,375 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | IndirectSee Footnote Below. | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 13,000 · Balance 0 F3: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30 | Direct | 0 |
Reported balance
After 2018-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-03-28 · Disposition to issuer · Disposed 119,000 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 119,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 111,000 · Balance 0 F5: This option will become exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 111,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 112,340 · Balance 0 F6: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 112,340 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 136,000 · Balance 0 F7: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 136,268 · Balance 0 F8: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,268 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: These 48,895 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,375 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 119,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option will become exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 111,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 112,340 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F8: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,268 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 1,165 | $165.65 | $192,982.25 |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,452 F5 · shares: 1,165 shares were withheld from the 2,597 restricted shares that vested on June 1, 2020. These 1,165 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,597 ordinary shares were awarded to Mr. Rosebrough on May 31, 2019 as part of an award of 10,388 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2020. These ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 1,413 | $165.65 | $234,063.45 |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,617 F4 · shares: 1,413 shares were withheld from the 3,097 restricted shares that vested on June 1, 2020. These 1,413 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax law, as determined by the Issuer. These 3,097 ordinary shares were awarded to Mr. Rosebrough on May 31, 2018 as part of an award of 12,388 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2020. These ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 1,839 | $165.65 | $304,630.35 |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,030 F3 · shares: 1,839 shares were withheld from the 4,000 restricted shares that vested on June 1, 2020. These 1,839 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,000 ordinary shares were awarded to Mr. Rosebrough on May 30, 2017 as part of an award of 16,000 restricted shares. These vested shares were valued at the NYSE closing market price on June 1, 2020. These ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:31 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 8,868 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034034 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,869 F1 · shares: All of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,217 on June 1, 2021; 2,217 on June 1, 2022; 2,217 on June 1, 2023 and 2,217 on June 3, 2024. F2 · balance_after: These 74,869 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 21:05 UTC | STERIS plc STE · Entity 3228 | GiftOrdinary Shares | 6,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033249 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 66,001 F1 · ownership.nature: These 66,001 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 32,360 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 2,597 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; and 2,597 on May 31, 2023 Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 21:33 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-20-011093 · doc4.xml · derivative · entry 7 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,085 Underlying: Ordinary Shares · 40,000 shares Expires 2016-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is part of an option to purchase 112,340 STERIS ordinary shares, of which 84,255 have fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 112,340 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 21:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 512 | $168.59 | $86,319.00 |
DisclosureSEC source: 0001209191-20-011093 · doc4.xml · nonDerivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,623 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $168.50 to $168.79 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F4 · balance_after: These 72,623 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 32,360 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 2,597 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; and 2,597 on May 31, 2023. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 21:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 39,488 | $168.00 | $6,634,094.57 |
DisclosureSEC source: 0001209191-20-011093 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,135 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $167.48 to $168.45 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 21:33 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 40,000 | $69.72 | $2,788,800.00 |
DisclosureSEC source: 0001209191-20-011093 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:33 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 44,255 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-20-011093 · doc4.xml · derivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,085 Underlying: Ordinary Shares · 44,255 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is part of an option to purchase 112,340 STERIS ordinary shares, of which 84,255 have fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 112,340 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 32,255 | $167.46 | $5,401,380.37 |
DisclosureSEC source: 0001209191-20-011093 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,623 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $167.13 to $168.07 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:33 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 44,255 | $69.72 | $3,085,458.60 |
DisclosureSEC source: 0001209191-20-011093 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 19, 2020 01:00 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantDeferred Stock Units · Derivative | 6,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000012 · wf-form4_158207399222455.xml · derivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,160 Underlying: Common Stock · 6,160 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) February 15, 2023, (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| November 20, 2019 Filed Nov 21, 2019 21:33 UTC | STERIS plc STE · Entity 3228 | GiftOrdinary Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-057612 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 0 F2 · ownership.nature: These ordinary shares were held by the reporting person's spouse as trustee of a revocable trust established for her benefit. Read SEC document |
| August 08, 2019 Filed Aug 8, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $67.98 | $0.00 |
DisclosureSEC source: 0001209191-19-045128 · doc4.xml · derivative · entry 9 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 44,000 shares Expires 2025-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option to purchase 111,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 111,000 Old STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 08, 2019 Filed Aug 8, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 11,135 | $154.32 | $1,718,353.20 |
DisclosureSEC source: 0001209191-19-045128 · doc4.xml · nonDerivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,623 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.02 to $154.56 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F5 · balance_after: These 60,623 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 32,360 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 2,597 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; and 2,597 on May 31, 2023. Read SEC document |
| August 08, 2019 Filed Aug 8, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 32,865 | $153.65 | $5,049,707.25 |
DisclosureSEC source: 0001209191-19-045128 · doc4.xml · nonDerivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,758 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $153.02 to $154.01 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 08, 2019 Filed Aug 8, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 44,000 | $67.98 | $2,991,120.00 |
DisclosureSEC source: 0001209191-19-045128 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 67,000 | $0.00 Strike: $67.98 | $0.00 |
DisclosureSEC source: 0001209191-19-045128 · doc4.xml · derivative · entry 8 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Ordinary Shares · 67,000 shares Expires 2025-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option to purchase 111,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 111,000 Old STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | GiftOrdinary Shares | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045128 · doc4.xml · nonDerivative · entry 7 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 6,000 F6 · ownership.nature: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 20,779 | $150.83 | $3,134,096.57 |
DisclosureSEC source: 0001209191-19-045128 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,623 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $150.48 to $151.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 37,721 | $149.93 | $5,655,509.53 |
DisclosureSEC source: 0001209191-19-045128 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,402 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $149.44 to $150.40 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 20:43 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 67,000 | $67.98 | $4,554,660.00 |
DisclosureSEC source: 0001209191-19-045128 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:34 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 2,179 | $134.07 | $292,138.53 |
DisclosureSEC source: 0001209191-19-034752 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,123 F1 · shares: 2,179 shares were withheld from the 4,681 restricted shares that vested on May 28, 2019. These 2,179 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,681 ordinary shares were awarded to Mr. Rosebrough on June 1, 2016 as part of an award of 18,724 restricted shares. These vested shares were valued at the NYSE closing market price on June 3, 2019. The remaining restrictions on these ordinary shares lapse as follows: 4,681 on June 1, 2020. F2 · balance_after: These 52,123 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 32,360 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 2,597 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; and 2,597 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 111,204 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · derivative · entry 15 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,204 Underlying: Ordinary Shares · 111,204 shares Expires 2029-05-31 F15 · derivative.exercise_date: This option becomes exercisable as follows: 27,801 on June 1, 2020; 27,801 on June 1, 2021; 27,801 on May 31, 2022 and 27,801 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 59,000 | $0.00 Strike: $53.52 | $0.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · derivative · entry 14 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 59,000 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 10,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 11 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,302 F12 · shares: All 10,388 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,597 on June 1, 2020; 2,597 on June 1, 2021; 2,597 on May 31, 2022 and 2,597 on May 31, 2023. F13 · balance_after: These 54,302 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,041 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 2,597 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; and 2,597 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,875 | $132.55 | $248,531.25 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 10 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,914 F8 · shares: This exercise and sale of a total of 59,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. F11 · price: Price reflects a weighted average sale price for multiple transactions ranging from $132.44 to $132.68 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 29,083 | $132.06 | $3,840,700.98 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 9 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,789 F8 · shares: This exercise and sale of a total of 59,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. F10 · price: Price reflects a weighted average sale price for multiple transactions ranging from $131.41 to $132.40 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 28,042 | $130.84 | $3,669,015.28 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 8 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,872 F8 · shares: This exercise and sale of a total of 59,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. F9 · price: Price reflects a weighted average sale price for multiple transactions ranging from $130.39 to $131.38 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 59,000 | $53.52 | $3,157,680.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 7 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. F8 · shares: This exercise and sale of a total of 59,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 1,436 | $133.68 | $191,964.48 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,914 F7 · shares: 1,436 shares were withheld from the 3,097 restricted shares that vested on May 31, 2019. These 1,436 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 3,097 ordinary shares were awarded to Mr. Rosebrough on May 31, 2018 as part of an award of 12,388 restricted shares. These vested shares were valued at the NYSE closing market price on May 31, 2019. The remaining restrictions on these ordinary shares lapse as follows: 3,097 on June 1, 2020; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $53.52 | $0.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · derivative · entry 13 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 Underlying: Ordinary Shares · 119,000 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. F3 · derivative.exercise_date: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,400 | $134.60 | $188,440.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,350 F2 · shares: This exercise and sale of a total of 60,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $134.53 to $134.69 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 27,922 | $134.18 | $3,746,573.96 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,750 F2 · shares: This exercise and sale of a total of 60,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $133.54 to $134.50 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 30,678 | $133.05 | $4,081,707.90 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,672 F2 · shares: This exercise and sale of a total of 60,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $132.53 to $133.52 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 60,000 | $53.52 | $3,211,200.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This exercise and sale of a total of 60,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019. F3 · shares: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 1,860 | $133.35 | $248,031.00 |
DisclosureSEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,350 F1 · shares: 1,860 shares were withheld from the 4,000 restricted shares that vested on May 30, 2019. These 1,860 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,000 ordinary shares were awarded to Mr. Rosebrough on May 30, 2017 as part of an award of 16,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2019. The remaining restrictions on these ordinary shares lapse as follows: 4,000 on May 30, 2020; and 4,000 on May 30, 2021. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:36 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 1,685 | $133.92 | $225,655.20 |
DisclosureSEC source: 0001209191-19-033443 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,210 F1 · shares: 1,685 shares were withheld from the 3,625 restricted shares that vested on May 28, 2019. These 1,685 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 3,625 ordinary shares were awarded to Mr. Rosebrough on August 10, 2015 as part of an award of 14,500 restricted shares. These vested shares were valued at the NYSE closing market price on May 28, 2019. F2 · balance_after: These 47,210 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 33,750 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 136,268 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · derivative · entry 7 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,268 Underlying: Ordinary Shares · 136,268 shares Expires 2028-05-31 F8 · price: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 136,268 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 136,268 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 136,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · derivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Underlying: Ordinary Shares · 136,000 shares Expires 2027-05-30 F7 · price: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 136,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 136,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 112,340 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · derivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,340 Underlying: Ordinary Shares · 112,340 shares Expires 2026-06-01 F6 · price: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 112,340 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 112,340 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 111,000 | Not disclosed Strike: $67.98 | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · derivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,000 Underlying: Ordinary Shares · 111,000 shares Expires 2025-08-10 F5 · price: This option becomes exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 111,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 111,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 119,000 | Not disclosed Strike: $53.52 | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,000 Underlying: Ordinary Shares · 119,000 shares Expires 2024-05-30 F4 · price: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option F4 · derivative.exercise_date: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 13,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · nonDerivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 13,000 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · ownership.nature: These ordinary shares are held by the reporting person's spouse as trustee of a revocable trust established for her benefit. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:36 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 48,895 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021606 · doc4.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,895 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2 · balance_after: These 48,895 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 37,375 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,625 on May 28, 2019; 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:03 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 136,268 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021564 · doc4.xml · derivative · entry 7 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 136,268 shares Expires 2028-05-31 F8 · price: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,268 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 34,067 on May 31, 2019; 34,067 on June 1, 2020; 34,067 on June 1, 2021 and 34,067 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,268 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:03 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 136,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021564 · doc4.xml · derivative · entry 6 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 136,000 shares Expires 2027-05-30 F7 · price: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 34,000 on May 30, 2018; 34,000 on May 30, 2019; 34,000 on June 1, 2020 and 34,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 136,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:03 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 112,340 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021564 · doc4.xml · derivative · entry 5 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 112,340 shares Expires 2026-06-01 F6 · price: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 112,340 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 28,085 on June 1, 2017; 28,085 on June 1, 2018; 28,085 on June 3, 2019 and 28,085 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 112,340 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:03 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 111,000 | Not disclosed Strike: $67.98 | Not disclosed |
DisclosureSEC source: 0001209191-19-021564 · doc4.xml · derivative · entry 4 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 111,000 shares Expires 2025-08-10 F5 · price: This option will become exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 111,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option will become exercisable as follows: 27,750 on May 28, 2016; 27,750 on May 28, 2017; 27,750 on May 28, 2018 and 27,750 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 111,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.